21/08/2026
ZhuoYi Biological's rabies vaccine demonstrates a strong quality and safety profile. Over the past five years, more than 40 million doses have been supplied, with an adverse event following immunization ( ) reporting rate of just 0.74 per 10,000 doses. Residual host cell protein and bovine serum albumin levels are only 1/8 and 1/18 of national standards, respectively, highlighting stringent purification and quality control.